Early Access

10-KPeriod: FY2023

AFLAC INC Annual Report, Year Ended Dec 31, 2023

Filed February 22, 2024For Securities:AFL

Summary

Aflac Incorporated reported solid financial performance for the fiscal year ending December 31, 2023. Total revenues reached $18.7 billion, with net earnings of $4.7 billion, or $7.78 per diluted share. Adjusted earnings were $3.7 billion, or $6.23 per diluted share, demonstrating the company's ability to manage its core insurance operations effectively. The company returned significant capital to shareholders, repurchasing approximately $2.8 billion of its common stock and increasing its quarterly cash dividend by 19.0% starting in the first quarter of 2024. The company's primary operations in Japan (Aflac Japan) continue to be the main earnings contributor, accounting for 60% of adjusted revenues. While Aflac Japan experienced a slight decrease in net earned premiums due to internal reinsurance transactions and policy maturities, its adjusted net investment income increased, driven by higher yields on U.S. dollar-denominated investments. Aflac U.S. showed growth in net earned premiums across several product lines, including life and disability, and dental and vision, supported by higher interest rates on its investment portfolio. Looking ahead, Aflac is focused on product development and distribution expansion in both markets, alongside technological modernization and operational efficiencies. The company maintains strong capital ratios in both Aflac Japan and Aflac U.S., aiming for a minimum Solvency Margin Ratio (SMR) of 500% for Japan and a combined Risk-Based Capital (RBC) ratio of approximately 400% for the U.S. operations, underscoring a commitment to financial strength and shareholder value.

Financial Statements
Beta
Revenue$18.70B
SG&A Expenses$3.17B
Operating Expenses$5.23B
Interest Expense$190.00M
Net Income$4.66B
EPS (Basic)$7.81
EPS (Diluted)$7.78
Shares Outstanding (Basic)596.17M
Shares Outstanding (Diluted)598.75M

Key Highlights

  • 1Aflac reported net earnings of $4.7 billion ($7.78 per diluted share) for the full year 2023.
  • 2Adjusted earnings were $3.7 billion ($6.23 per diluted share), indicating strong core insurance operations.
  • 3The company repurchased $2.8 billion of its common stock in 2023 and announced a 19.0% increase in its quarterly dividend for 2024.
  • 4Aflac Japan remains the largest contributor to earnings, with 60% of total adjusted revenues.
  • 5Aflac U.S. saw an increase in net earned premiums, driven by growth initiatives and higher yields on its investment portfolio.
  • 6Shareholders' equity grew to $22.0 billion ($38.00 per share) by year-end 2023.
  • 7The company maintains robust capital positions, with Aflac Japan's SMR at 1,219% and a combined U.S. RBC ratio of 710%.

Frequently Asked Questions